FDA approves Baxter's clindamycin injection in saline

The Food and Drug Administration on Wednesday approved Baxter International's clindamycin injection in saline.

Clindamycin is a common antibiotic used to treat serious infections when penicillin may not be used.

The injection, available in three different formulas, offers physicians an alternative for patients who cannot receive the typical clindamycin injection in dextrose.

More articles on supply chain:

Across enemy lines: Insurer recruits former drug reps to push more generics
Joslin Diabetes Center affiliate HSHS Medical Group to offer MiniMed insulin pump
FDA OKs Claret Medical's stroke prevention device

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers